$265.00
+ 0.50+ 0.19%
Alpaca · SIPUpdated 14:2415 Minutes Delayed
No data
No data
This data isn't available right now.
Balance-sheet ratios aren't available for this company.
It is an automated pre-screen based on the line of business and AAOIFI's widely used financial thresholds; a final judgement rests with your own school of thought and the certification boards that audit the filings.
The interest-income test (5% of revenue) needs a revenue breakdown our free data source doesn't provide, so that criterion isn't screened.
$265.00
Alpaca · SIPUpdated 14:2415 Minutes Delayed
Couldn't load data
Alnylam pioneered RNA interference therapy, silencing faulty proteins at the genetic source before they are made.
CacheUpdated 13:02May Be Out Of Date
No data
Industry: Biotechnology
Average close over the last 50, 100 and 200 trading days. The percentage next to it is how far the current price sits from that average.